Affibody是一家處于瑞典臨床臨床階段的私有生物技術(shù)公司,致力于基于其*的專有技術(shù)平臺(Affibody®分子和Albumod™)開發(fā)利用下一代生物療法的綜合生物制藥公司。
該公司經(jīng)營著眼于重點(diǎn)的實(shí)驗(yàn)醫(yī)學(xué)模型,目前擁有三個(gè)臨床階段計(jì)劃。前兩個(gè)是分別針對牛皮癬和B細(xì)胞驅(qū)動(dòng)的自身免疫性疾病的治療方案。第三個(gè)程序是診斷成像程序,主要針對轉(zhuǎn)移性乳腺癌。
Affibody與AbClon,Alexion,Biotest,Daewoong,Daiichi Sankyo,GE Healthcare和Swedish Orphan Biovitrum等多家公司保持著持續(xù)的商業(yè)關(guān)系。
Affibody AB是Patricia Industries的控股公司。
瑞典Affibody2020年價(jià)格表
貨號 | 品名 | 規(guī)格 | 價(jià)格 | 品牌 |
10.2023.01.0005 | Anti-EGFR imaging agent | 500 µg | 14300 | affibody2020 |
10.2023.01.0001 | Anti-EGFR imaging agent | 100 µg | 3400 | affibody2020 |
10.1861.01.0001 | Anti-HER2, imaging agent | 100 µg | 6300 | affibody2020 |
10.1861.01.0005 | Anti-HER2, imaging agent | 500 µg | 29100 | affibody2020 |
10.2046.01.0005 | Imaging agent negative control | 500 µg | 9300 | affibody2020 |
10.1886.01.0001 | Anti-EGFR unconjugated | 100 µg | 3400 | affibody2020 |
10.1886.01.0005 | Anti-EGFR unconjugated | 500 µg | 9300 | affibody2020 |
10.1886.03.0001 | Anti-EGFR, fluorescein conjugated | 100 µg | 9300 | affibody2020 |
10.1246.04.0002 | Anti-EGFR, agarose immobilized | 200 µl | 11000 | affibody2020 |
10.1246.04.9002 | Anti-EGFR, IP kit | 200 µl | 12300 | affibody2020 |
10.0817.01.0001 | Anti-HER2, unconjugated | 100 µg | 3400 | affibody2020 |
10.0817.01.0005 | Anti-HER2, unconjugated | 500 µg | 9300 | affibody2020 |
10.0817.02.0001 | Anti-HER2, biotin conjugated | 100 µg | 9300 | affibody2020 |
10.0817.03.0001 | Anti-HER2, fluorescein conjugated | 100 µg | 9300 | affibody2020 |
10.0817.04.0002 | Anti-HER2, agarose immobilized | 200 µl | 11000 | affibody2020 |
10.0817.04.9002 | Anti-HER2, IP kit | 200 µl | 12300 | affibody2020 |
10.0817.05.0002 | Anti-HER2, HRP conjugated | 200 µl | 9300 | affibody2020 |
10.0644.01.0010 | Anti-HSA, unconjugated | 1 mg | 14300 | affibody2020 |
10.0644.01.0050 | Anti-HSA, unconjugated | 5 mg | 49900 | affibody2020 |
10.0644.02.0005 | Anti-HSA, biotin conjugated | 500 µg | 14300 | affibody2020 |
10.1150.01.0005 | Anti-IgA, unconjugated | 500 µg | 7900 | affibody2020 |
10.1150.01.0050 | Anti-IgA, unconjugated | 5 mg | 49900 | affibody2020 |
10.0816.01.0010 | Anti-IgE, unconjugated | 1 mg | 14300 | affibody2020 |
10.0623.01.0010 | Anti-IgG, unconjugated | 1 mg | 14300 | affibody2020 |
10.0623.01.0050 | Anti-IgG, unconjugated | 5 mg | 49900 | affibody2020 |
10.0623.02.0005 | Anti-IgG, biotin conjugated | 500 µg | 14300 | affibody2020 |
10.1329.01.0005 | Anti-IgM, unconjugated | 500 µg | 9300 | affibody2020 |
10.1329.01.0050 | Anti-IgM, unconjugated | 5 mg | 49900 | affibody2020 |
10.0814.01.0010 | Anti-Insulin, unconjugated | 1 mg | 14300 | affibody2020 |
10.0814.01.0050 | Anti-Insulin, unconjugated | 5 mg | 49900 | affibody2020 |
10.0841.01.0010 | Anti-TNF-α, unconjugated | 1 mg | 14300 | affibody2020 |
10.0841.01.0050 | Anti-TNF-α, unconjugated | 5 mg | 49900 | affibody2020 |
10.0841.04.0002 | Anti-TNF-α, agarose immobilized | 200 µl | 9300 | affibody2020 |
10.0841.04.9002 | Anti-TNF-α, IP kit | 200 µl | 11900 | affibody2020 |
10.1105.01.0005 | Anti-Transferrin, unconjugated | 500 µg | 9300 | affibody2020 |
10.1105.01.0050 | Anti-Transferrin, unconjugated | 5 mg | 49900 | affibody2020 |
10.1278.01.0005 | Anti-Fibrinogen, unconjugated | 500 µg | 9300 | affibody2020 |
10.1278.01.0050 | Anti-Fibrinogen, unconjugated | 5 mg | 49900 | affibody2020 |
20.1000.01.0005 | Goat Anti-Affibody® IgG | 500 µl | 7900 | affibody2020 |
電話
QQ咨詢
4006551678